PNI, a combination of serum albumin and lymphocyte count, has been reported as a useful predictor in several malignancies (eg. Lung cancer,10 breast cancer,9 colorectal cancer,11 and renal cell carcinoma 18). This evidence concerns the gene ALB and breast cancer.